The Effect of Acceptance and Commitment of Bipolar Disorder Patients - Trial NCT06113887
Access comprehensive clinical trial information for NCT06113887 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Gaziantep and is currently Recruiting. The study focuses on Bipolar Disorder. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Gaziantep
Timeline & Enrollment
N/A
Dec 01, 2022
Dec 15, 2023
Primary Outcome
The effect of psychoeducation based on acceptance and commitment therapy on psychological flexibility level in bipolar disorder patients
Summary
This study will be conducted to determine the effect of acceptance and commitment
 therapy-based psychoeducation on psychological flexibility and impulsivity levels in patients
 with bipolar disorder. This study was planned as a randomised controlled experimental study.
 The study will be conducted with 60 patients (Intervention: 30, Control: 30) in the euthymic
 stage diagnosed with bipolar disorder who applied to Adฤฑyaman Besni State Hospital psychiatry
 outpatient clinic using randomisation method. Introductory Information Form about
 socio-demographic characteristics, Psychological Flexibility Scale and Barratt Impulsivity
 Scale -11 Short Form will be used for data collection. Acceptance and Commitment Therapy
 Based Psychoeducation will be applied to the patients in the intervention group in the form
 of group education (consisting of 5-7 people), one session per week for eight weeks; no
 intervention will be applied to the control group. Pre-tests will be applied to the patients
 in the intervention and control groups just before the training, post-test will be applied to
 the intervention group immediately after the training sessions are completed, and follow-up
 test will be applied one month after the post-test, i.e. in the 12th week. After the pre-test
 was applied to the control group, the post-test will be applied in the 8th week and the
 follow-up test will be applied in the 12th week without any intervention. Repeated Measures
 Analysis of Variance was used to compare the scale scores and Fisher Least Significant
 Difference test was used for multiple comparisons of Group*Time interaction. Permission was
 obtained from the University Ethics Committee, the relevant institution and the individuals
 participating in the study.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06113887
Non-Device Trial